Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

312 Press Releases
DateTitleCompany
18 Feb 17 Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601 Takeda ,
Published by
PharmiWeb.com
17 Feb 17 Five-Year Open-Label Prospective Study Data Presented at the 12th Congress of European Crohn's and Colitis Organisation (ECCO) Provides Information on the Long-Term Use of Vedolizumab in Adult Patients with Moderate to Severely Active Ulcerative Colitis and Crohn's Disease Takeda Pharmaceuticals Company Limited,
Published by
PR Newswire
17 Feb 17 Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn’s Disease Patients with Cx601 Takeda,
Published by
Business Wire
16 Feb 17 Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc. Takeda Pharmaceutical Company Limited,
Published by
Business Wire
08 Feb 17 Takeda Presents $1 Million Gift to the Koch Institute for Integrative Cancer Research at MIT to Support Immuno-oncology Research Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Jan 17 Takeda Recognized as One of the Global 100 Most Sustainable Corporations for Second Consecutive Year Takeda Pharmaceutical Company Limited,
Published by
Business Wire
19 Jan 17 Takeda Commences Cash Tender Offer for All Outstanding Shares of ARIAD Pharmaceuticals, Inc. Takeda Pharmaceutical Company Limited,
Published by
Business Wire
18 Jan 17 Takeda and Ovid Therapeutics Announce Innovative Clinical Development and Commercialization Collaboration for TAK-935 in Rare Pediatric Epilepsies Takeda Pharmaceutical Company Limited,
Published by
Business Wire
11 Jan 17 Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies Takeda Pharmaceutical Company Limited,
Published by
Business Wire
09 Jan 17 Takeda to buy Ariad under $5.2-billion deal, boosting oncology portfolio Takeda ,
Published by
PharmiWeb.com
05 Jan 17 Takeda and PvP Biologics Announce Development Agreement around Novel Therapeutic for Celiac Disease Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Dec 16 Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases Takeda Pharmaceutical Company Limited,
Published by
Business Wire
30 Nov 16 NINLARO® (ixazomib) Receives Conditional Approval from the European Commission to Treat Relapsed or Refractory Multiple Myeloma Takeda UK
30 Nov 16 Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Nov 16 NINLARO™ (ixazomib) Receives Conditional Approval from the European Commission to Treat Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Nov 16 Results of Study of Febuxostat on the Frequency of Acute Gout Flares in Early Gout Takeda Pharmaceuticals U.S.A., Inc.,
Published by
Business Wire
10 Nov 16 Takeda and the New York Academy of Sciences to Honor Commitment to Innovation in Key Areas of Therapeutic Focus Takeda Pharmaceutical Company Limited,
Published by
Business Wire
07 Nov 16 Takeda and Koneksa Health Announce Strategic Collaboration to Use Digital Health Tools in Clinical Trials Takeda Pharmaceutical Company Limited,
Published by
Business Wire
20 Sep 16 Takeda and Zydus Cadila partner to address the global threat of Chikungunya Takeda Pharmaceutical Company Limited,
Published by
Business Wire
16 Sep 16 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma Takeda Pharmaceutical Company Limited,
Published by
Business Wire
13 Sep 16 Takeda Supports Global Expansion of the American Cancer Society’s Relay For Life (RFL) Takeda ,
Published by
PharmiWeb.com
17 Oct 16 Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies Takeda Pharmaceutical Company Limited,
Published by
PR Newswire
21 Sep 16 Takeda and Affilogic enter into Research Collaboration to Develop Nanofitin®-based Therapies in Central Nervous System Takeda Pharmaceutical Company Limited,
Published by
Business Wire
19 Sep 16 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma Takeda ,
Published by
PharmiWeb.com
13 Sep 16 Takeda Supports Global Expansion of the American Cancer Society's Relay For Life (RFL) Takeda ,
Published by
PharmiWeb.com
30 Sep 16 Takeda Announces Winners From Its Depression Care Challenge Competition Takeda ,
Published by
PharmiWeb.com
10 Oct 16 Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Nov 16 Takeda Donates 1 Billion Yen as an Exclusive Partner to the United Nations Foundation for "Global Measles Vaccination for Children" Program Takeda Pharmaceutical Company Limited,
Published by
Business Wire
02 Nov 16 Takeda: CSR Programs Focusing on Maternal and Child Health Takeda Pharmaceutical Company Limited,
Published by
Business Wire
28 Oct 16 Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance Takeda Pharmaceutical Company Limited,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.